Abdi İbrahim İlaç Sanayi ve Ticaret AŞ 2016 SR
The report highlights Abdi Ibrahim's sustainability performance and achievements during the 2015-2016 period. The company prepared its third sustainability report using an integrated approach in accordance with GRI G4 Core, UNGC, and WEPs criteria. Key milestones include laying the foundation for AbdiBio, Turkey's largest biotechnological manufacturing facility, and starting operations at its modern production facility in Kazakhstan. Abdi Ibrahim maintained its leadership in the Turkish pharmaceutical sector, achieving a 6.3% market share in 2016. The company also successfully completed the renovation of the historical Sultan Bayezid II Edirne Hospital as a major corporate social responsibility project.
Company: Abdi İbrahim İlaç Sanayi ve Ticaret AŞ
Country: Turkey
Year: 2016
Type: SR
Pages: 76
Abdi İbrahim İlaç Sanayi ve Ticaret AŞ
The report highlights Abdi Ibrahim's sustainability performance and achievements during the 2015-2016 period. The company prepared its third sustainability report using an integrated approach in accordance with GRI G4 Core, UNGC, and WEPs criteria. Key milestones include laying the foundation for AbdiBio, Turkey's largest biotechnological manufacturing facility, and starting operations at its modern production facility in Kazakhstan. Abdi Ibrahim maintained its leadership in the Turkish pharmaceutical sector, achieving a 6.3% market share in 2016. The company also successfully completed the renovation of the historical Sultan Bayezid II Edirne Hospital as a major corporate social responsibility project.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2015 - Dec 31, 2016
Fiscal Year
2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Renewable Energy
Water Consumption
Employees